VASOPRESSIN
| Brand name | VASOPRESSIN IN SODIUM CHLORIDE 0.9% |
|---|---|
| Active ingredient | VASOPRESSIN |
| Strength | 40UNITS/100ML (0.4UNITS/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | September 2023 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12447190 | September 2044 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.